Archit Organosys
BSE: ARCHITORG · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Archit Organosys's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Archit Organosys Limited is an Ahmedabad-based chemical manufacturer specialising in the production of Monochloro Acetic Acid and Sodium Monochloro Acetate. The company serves diverse sectors including pharmaceuticals, agrochemicals, and food additives, while also engaging in the trading of chemical products and the manufacturing of adhesives and sealants.
Business Model
The company generates revenue through the manufacturing and sale of chemical intermediates and the trading of various chemical products. It leverages its manufacturing facilities in Gujarat to supply both domestic and international industrial markets.
Management Commentary
Management focuses on capacity expansion and technical upgrades to enhance the production of high-purity chemical derivatives. The company aims to strengthen its position within the organic chemical supply chain to meet evolving industrial demand.
Growth Outlook
Growth is driven by ongoing capacity expansions and technical improvements to its manufacturing processes. The company is also diversifying its portfolio through the expansion of its adhesives and sealants segment.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical feedstocks can significantly impact profit margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate costly operational adjustments.
- Cyclical Demand. The company's performance is tied to the cyclical nature of the pharmaceutical and agrochemical industries it serves.
- Geopolitical and Trade Risks. As an exporter, the company is exposed to international trade barriers and currency exchange rate fluctuations.
Start your research today
Unlock AI insights, financials, peers and live data on Archit Organosys and 5,000+ companies — free.
Key Metrics
REVENUE
₹141 Cr
TTM · standalone
NET PROFIT
₹8 Cr
TTM · standalone
EPS
₹3.92
TTM · standalone
RETURN ON EQUITY
11.3%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
16.9%
TTM · standalone
P/E
14.5x
Q4 FY26 · standalone
EV/EBITDA
5.1x
Q4 FY26 · standalone
EBITDA MARGIN
13.7%
TTM · standalone
NET PROFIT MARGIN
5.5%
Q4 FY26 · standalone
DEBT TO EQUITY
0.3x
Q4 FY26 · standalone
Peers · Commodity Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Archit OrganosysARCHITORG | ₹131 Cr | 16.24 | 7.97 | 12.2% | 13.7% | 11.3% | 16.9% | +42.5% |
Blue Pearl Agriventures LimitedBPAGRI | ₹525 Cr | — | — | — | 2.7% | — | — | -92.2% |
Primo ChemicalsPRIMO | ₹517 Cr | 32.82 | 7.31 | -2.7% | 15.8% | 4.0% | 7.1% | -16.6% |
POCL EnterprisesPOEL | ₹460 Cr | 10.53 | 7.57 | — | 5.3% | 21.3% | 33.7% | -37.2% |
Mangalam OrganicMANORG | ₹437 Cr | 21.41 | 8.88 | 17.3% | 13.6% | 6.8% | 15.9% | -7.2% |
Lords Chloro Alkali LimitedLORDSCHLO | ₹402 Cr | 11.52 | 7.91 | 29.8% | 17.3% | 15.6% | 14.1% | -18.7% |
As of Q4 FY26
Financials
Archit Organosys
BSE: ARCHITORG · Commodity Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Archit Organosys's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Archit Organosys Limited is an Ahmedabad-based chemical manufacturer specialising in the production of Monochloro Acetic Acid and Sodium Monochloro Acetate. The company serves diverse sectors including pharmaceuticals, agrochemicals, and food additives, while also engaging in the trading of chemical products and the manufacturing of adhesives and sealants.
Business Model
The company generates revenue through the manufacturing and sale of chemical intermediates and the trading of various chemical products. It leverages its manufacturing facilities in Gujarat to supply both domestic and international industrial markets.
Management Commentary
Management focuses on capacity expansion and technical upgrades to enhance the production of high-purity chemical derivatives. The company aims to strengthen its position within the organic chemical supply chain to meet evolving industrial demand.
Growth Outlook
Growth is driven by ongoing capacity expansions and technical improvements to its manufacturing processes. The company is also diversifying its portfolio through the expansion of its adhesives and sealants segment.
Key Risks
- Raw Material Price Volatility. Fluctuations in the cost of key chemical feedstocks can significantly impact profit margins.
- Regulatory and Environmental Compliance. The chemical manufacturing sector is subject to stringent environmental regulations that may necessitate costly operational adjustments.
- Cyclical Demand. The company's performance is tied to the cyclical nature of the pharmaceutical and agrochemical industries it serves.
- Geopolitical and Trade Risks. As an exporter, the company is exposed to international trade barriers and currency exchange rate fluctuations.
Start your research today
Unlock AI insights, financials, peers and live data on Archit Organosys and 5,000+ companies — free.
Key Metrics
REVENUE
₹141 Cr
TTM · standalone
NET PROFIT
₹8 Cr
TTM · standalone
EPS
₹3.92
TTM · standalone
RETURN ON EQUITY
11.3%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
16.9%
TTM · standalone
P/E
14.5x
Q4 FY26 · standalone
EV/EBITDA
5.1x
Q4 FY26 · standalone
EBITDA MARGIN
13.7%
TTM · standalone
NET PROFIT MARGIN
5.5%
Q4 FY26 · standalone
DEBT TO EQUITY
0.3x
Q4 FY26 · standalone
Peers · Commodity Chemicals
As of Q4 FY26